These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20596732)

  • 21. C-reactive protein and the MASCC risk index identify high-risk patients with febrile neutropenia and hematologic neoplasms.
    Combariza JF; Lombana M; Pino LE; Arango M
    Support Care Cancer; 2015 Apr; 23(4):1009-13. PubMed ID: 25270848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.
    Ahn S; Lee YS; Chun YH; Kwon IH; Kim W; Lim KS; Kim TW; Lee KH
    Support Care Cancer; 2011 Aug; 19(8):1151-8. PubMed ID: 20552376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice.
    Innes H; Lim SL; Hall A; Chan SY; Bhalla N; Marshall E
    Support Care Cancer; 2008 May; 16(5):485-91. PubMed ID: 17899215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can MASCC and CISNE scores predict delays of lung cancer chemotherapy after febrile neutropenia?
    Ono Y; Hayama N; Hattori S; Ito Y; Oguma T; Sakamaki F; Asano K
    Thorac Cancer; 2022 Dec; 13(24):3504-3509. PubMed ID: 36330990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Risk Stratification Tools Be Utilized to Safely Discharge Low-Risk Febrile Neutropenic Patients from the Emergency Department?
    Chen AY; Gottlieb M; Vilke GM; Coyne C
    J Emerg Med; 2023 Jan; 64(1):111-118. PubMed ID: 36641256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
    El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteremia in adult cancer patients with apparently stable febrile neutropenia: data from a cohort of 692 consecutive episodes from a single institution.
    Carmona-Bayonas A; Fonseca PJ; Font C; Martínez-García J; Torrella F; Urrego E; Castaño P; Navarrete A; Antonio-Rebolla M; Gómez JG; Vincente V; Ayala F
    J Community Support Oncol; 2014 Sep; 12(9):312-20. PubMed ID: 25848908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality.
    Sütcüoğlu O; Akdoğan O; İnci BK; Gürler F; Özdemir N; Yazıcı O
    Support Care Cancer; 2021 Feb; 29(2):1047-1053. PubMed ID: 32583058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent factors for prediction of poor outcomes in patients with febrile neutropenia.
    Günalp M; Koyunoğlu M; Gürler S; Koca A; Yeşilkaya I; Öner E; Akkaş M; Metin Aksu N; Demirkan A; Polat O; Elhan AH
    Med Sci Monit; 2014 Oct; 20():1826-32. PubMed ID: 25282155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
    Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
    Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.
    Zhang S; Wang Q; Ling Y; Hu X
    BMC Cancer; 2015 Feb; 15():42. PubMed ID: 25763661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients.
    Horasan ES; Ersoz G; Tombak A; Tiftik N; Kaya A
    Med Sci Monit; 2011 May; 17(5):CR304-9. PubMed ID: 21525814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10.
    Uys A; Rapoport BL; Fickl H; Meyer PW; Anderson R
    Eur J Cancer Care (Engl); 2007 Nov; 16(6):475-83. PubMed ID: 17944761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of complete blood count parameters to predict poor outcomes in cancer patients with febrile neutropenia presenting to the emergency department.
    Choi A; Park I; Lee HS; Chung J; Kim MJ; Park YS
    Ann Med; 2022 Dec; 54(1):599-609. PubMed ID: 35175159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for poor prognosis febrile neutropenia.
    Ahn S; Lee YS
    Curr Opin Oncol; 2012 Jul; 24(4):376-80. PubMed ID: 22476191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inpatient versus outpatient management of neutropenic fever in gynecologic oncology patients: is risk stratification useful?
    Gunderson CC; Farrell R; Dinh BC; Thomas ED; Vesely SK; Lauer JK; Kao L; Chopra S; McMeekin DS; Moore KN
    Gynecol Oncol; 2013 Sep; 130(3):411-5. PubMed ID: 23791827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
    Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
    Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
    Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
    Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergency Ambulatory Management of Low-Risk Febrile Neutropenia: Multinational Association for Supportive Care in Cancer Fits-Real-World Experience From a UK Cancer Center.
    Marshall W; Campbell G; Knight T; Al-Sayed T; Cooksley T
    J Emerg Med; 2020 Mar; 58(3):444-448. PubMed ID: 31744709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancer.
    Paganini HR; Aguirre C; Puppa G; Garbini C; Ruiz Guiñazú J; Ensinck G; Vrátnica C; Flynn L; Iacono M; Zubizarreta P;
    Cancer; 2007 Jun; 109(12):2572-9. PubMed ID: 17492687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.